Analyst downgrades: RHT, COF and NVO
Filed under: Analyst upgrades and downgrades, Red Hat Inc (RHT), SLM Corp (SLM)
MOST NOTEWORTHY: Red Hat, Capital One and Novo Nordisk were today’s noteworthy downgrades:
- Banc of America downgraded shares of Red Hat (NYSE: RHT) to Neutral from Buy, despite expectations for solid Q3 results, due to a lack of billings catalysts and their belief that JBoss continues to have trouble gaining momentum.
- Capital One (NYSE: COF) was lowered to Hold from Buy at Jefferies, as they expect limited upside until investors have improved visibility on the extent and timing of credit losses.
- Merrill downgraded Novo Nordisk(NYSE: NVO) to Neutral from Buy on a lack of near-term catalysts with the company’s diabetes and obesity drug-trial info being already presented.
OTHER DOWNGRADES:
- Goldman removed CME Group (NYSE: CME) from its Conviction Buy List.
- JP Morgan lowered Plantronics (NYSE: PLT) to Underweight from Neutral.
- Thomas Weisel downgraded SLM Corp (NYSE: SLM) to Market Weight from Overweight.
Permalink | Email this | Comments
Original post by Eric Buscemi
Related Articles
Analyst downgrades: STO, PT and STEC Top Pre-Market Analyst Downgrades (KELYA, KLAC, LRCX, MRVL, PNY, RHI, SNDA, XLNX) Analyst downgrades: PRTS, TRAK and APPY CIBC World Markets downgrades Krispy Kreme (KKD) Top Analyst Upgrades & Downgrades (CEG, DENN, ODSY, ARO, D, EXEL, JNJ, VOCS, ZGEN)
No comments yet. Be the first.
Leave a reply






























